CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The CCAAT/enhancer binding protein epsilon (C/EBPepsilon) is a nuclear transcription factor expressed predominantly in myeloid cells and implicated as a potential regulator of myeloid differentiation. We show that it was rapidly induced in the acute promyelocytic leukemia (APL) cell line NB4 during granulocytic differentiation after exposure to retinoic acid (RA). Our data suggest that induction of C/EBPepsilon expression was through the retinoic acid receptor alpha (RARalpha) pathway. Reporter gene studies showed that C/EBPepsilon promoter/enhancer activity increased in a retinoid-dependent fashion via the retinoic acid response element (RARE) present in the promoter region of C/EBPepsilon. The RA-induced expression of C/EBPepsilon markedly increased in U937 myelomonoblasts that were induced to express promyelocytic leukemia/RARalpha (PML/RARalpha), but not in those induced to express promyelocytic leukemia zinc finger/RARalpha (PLZF/RARalpha). In retinoid-resistant APL cell lines, C/EBPepsilon either is not induced or is induced only at very high concentrations of RA (>/=10(-6) M). In addition, forced expression of C/EBPepsilon in the U937 myelomonoblastic leukemia cells mimicked terminal granulocytic differentiation, including morphologic changes, increased CD11b/CD66b expression, and induction of secondary granule protein expression. Our data strongly suggest that C/EBPepsilon is a downstream target gene responsible for RA-induced granulocytic differentiation of APL cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Differentiation induction of haematological malignant cells as well as normal HSC differentiation is mediated by a stochiometric ratio of transcription factors GATA-1 and PU.1 [41], which broadly determine lineage and cooperate with more specific transcription factors such as RAR receptor and CEBP family members [59, 93, 94].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“Retinoids and their nuclear receptors appear to have multiple functions in the regulation of normal cellular differentiation (1).”
BackgroundUse of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
Background9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
BackgroundUmesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundMethodLuckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701 · cited 6×
“A CAT reporter construct that does not contain a putative RARE site (PRE) was used as a negative control.”
MethodInfluentialKliewer, S. A., Umesono, K., Mangelsdorf, D. J., & Evans, R. M. (1992) · Nature · doi:10.1038/355446a0 · Cited by 1,489 · cited 1×
“The retinoic acid receptor (RAR) forms a heterodimeric complex with the retinoid X receptor (RXR) and has an important function in the transactivation of myeloid-specific genes (2, 3).”
BackgroundKakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Self-citationde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundDifferentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
BackgroundSelf-citation9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., ratzeisen, C., Rosenberger, M., Lovey, A., et al. (1992) · Nature · doi:10.1038/355359a0 · Cited by 1,222 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
Background
Research works printed but not linked: 6
- Zhang, 1996, Curr Top Microbiol Immunol, 211, 137
- Cook, 1996, Oncogene, 13, 1789
- Park, 1994, Oncogene, 9, 1899
- Guidez, 1994, Leukemia, 8, 312
- Testa, 1994, Cancer Res, 54, 4508
- Khanna-Gupta, 1996, Curr Top Microbiol Immunol, 211, 165
Cited by
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., & Bozzoni, I. (2005) · Cell · doi:10.1016/j.cell.2005.09.023 · Cited by 894
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
“Transcriptional activation by RAR may trigger differentiation (Park et al., 1999; Rochette-Egly and Chambon, 2001), cellcycle arrest (Donato et al.”
BackgroundDisruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
“For example, the ability of all- trans retinoic acid (ATRA) to induce differentiation of ACUTE PROMYELOCYTIC LEUKAEMIA (APL) cells might be mediated by C/EBP factors — most notably, C/EBPβ and C/EBP&epsi”
BackgroundZhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.11.006 · Cited by 504
Metadata
- Authors
- Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Lady Davis Institute for Medical Research (CA)
- Corresponding author
- Park, Dorothy J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-05-15
- Volume
- 103
- Issue
- 10
- Pages
- 1399-1408
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408448
- OpenAlex
- W2042117566
- Cited by
- 187
- References
- 55
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 1 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 11 · 2013: 6 · 2012: 6
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- University of California, Los Angeles
- Jonsson Comprehensive Cancer Center
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- acute promyelocytic leukemia, retinoic acid, retinoic acid receptor alpha, retinoic acid response element, granulocytic differentiation, PML-RARα, PLZF-RARα, retinoid resistance, transcriptional regulation, myeloid differentiation, NB4 cells, U937 cells
- MeSH terms
- Retinoic Acid Receptor alpha, Cell Differentiation, DNA-Binding Proteins, Drug Resistance, Enhancer Elements, Genetic, Humans, Nuclear Proteins, Promoter Regions, Genetic, Retinoids, Tretinoin, Tumor Cells, Cultured, Leukemia, Promyelocytic, Acute, Gene Expression, Genes, Reporter, Receptors, Retinoic Acid, U937 Cells, CCAAT-Enhancer-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment. https://app.cochat.ai/papers/10.1172/jci2887
- The paper
- Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P. (1999). CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment. Journal of Clinical Investigation. https://doi.org/10.1172/jci2887
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.